1. Home
  2. VABK vs TNXP Comparison

VABK vs TNXP Comparison

Compare VABK & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$39.46

Market Cap

212.3M

Sector

Finance

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$15.19

Market Cap

194.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
TNXP
Founded
1998
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.3M
194.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VABK
TNXP
Price
$39.46
$15.19
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$70.00
AVG Volume (30 Days)
8.7K
492.0K
Earning Date
01-23-2026
11-10-2025
Dividend Yield
3.54%
N/A
EPS Growth
14.22
N/A
EPS
3.30
N/A
Revenue
$56,512,000.00
$10,299,000.00
Revenue This Year
N/A
$2.96
Revenue Next Year
N/A
$750.19
P/E Ratio
$12.33
N/A
Revenue Growth
10.39
N/A
52 Week Low
$33.66
$6.76
52 Week High
$44.57
$69.97

Technical Indicators

Market Signals
Indicator
VABK
TNXP
Relative Strength Index (RSI) 50.64 38.11
Support Level $39.00 $14.94
Resistance Level $40.59 $15.68
Average True Range (ATR) 0.78 0.87
MACD -0.23 -0.15
Stochastic Oscillator 33.37 8.81

Price Performance

Historical Comparison
VABK
TNXP

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: